Theragen Etex Co.,Ltd. (KOSDAQ:066700)
South Korea · Delayed Price · Currency is KRW 3,130.00
+5.00 (0.16%)
At close: Apr 17, 2026
Theragen Etex Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 271,590 | 249,625 | 216,470 | 190,769 | 166,567 |
Other Revenue | - | - | -0 | -0 | - |
| 271,590 | 249,625 | 216,470 | 190,769 | 166,567 | |
Revenue Growth (YoY) | 8.80% | 15.32% | 13.47% | 14.53% | 16.46% |
Cost of Revenue | 130,576 | 123,644 | 116,344 | 113,363 | 105,392 |
Gross Profit | 141,013 | 125,981 | 100,126 | 77,406 | 61,175 |
Selling, General & Admin | 123,116 | 106,396 | 80,555 | 59,731 | 52,810 |
Research & Development | 4,359 | 4,128 | 4,044 | 5,038 | 6,515 |
Amortization of Goodwill & Intangibles | 40.74 | 84.5 | 88.54 | 78.04 | 216.99 |
Other Operating Expenses | 933.52 | 764.24 | 276.75 | 405.44 | 261.95 |
Operating Expenses | 130,800 | 114,335 | 88,653 | 65,553 | 68,602 |
Operating Income | 10,213 | 11,646 | 11,473 | 11,853 | -7,427 |
Interest Expense | -2,332 | -2,676 | -2,418 | -1,343 | -1,691 |
Interest & Investment Income | 979.03 | 776.69 | 799.02 | 340.94 | 327.69 |
Earnings From Equity Investments | - | 5,695 | - | - | - |
Currency Exchange Gain (Loss) | -26.15 | 126.41 | 2.6 | 3.79 | 97.9 |
Other Non Operating Income (Expenses) | -1,547 | -2,486 | 396.13 | -369.03 | -2,136 |
EBT Excluding Unusual Items | 7,287 | 13,082 | 10,253 | 10,486 | -10,829 |
Gain (Loss) on Sale of Investments | 10,276 | -56,036 | 22,164 | -60.85 | 12.93 |
Gain (Loss) on Sale of Assets | 13.48 | 150.68 | -46.62 | 4,231 | -219.2 |
Asset Writedown | - | -26.22 | -62.69 | -800.7 | -1,477 |
Other Unusual Items | -37.43 | -329.08 | 439.82 | - | -163.19 |
Pretax Income | 17,539 | -43,159 | 32,747 | 13,855 | -12,676 |
Income Tax Expense | 5,793 | -3,018 | 3,069 | 1,428 | -1,291 |
Earnings From Continuing Operations | 11,746 | -40,141 | 29,679 | 12,428 | -11,385 |
Earnings From Discontinued Operations | - | 860.46 | -1,287 | -1,477 | - |
Net Income to Company | 11,746 | -39,281 | 28,392 | 10,951 | -11,385 |
Minority Interest in Earnings | -1,145 | -1,704 | -2,180 | -1,389 | -469.31 |
Net Income | 10,600 | -40,985 | 26,211 | 9,561 | -11,854 |
Net Income to Common | 10,600 | -40,985 | 26,211 | 9,561 | -11,854 |
Net Income Growth | - | - | 174.14% | - | - |
Shares Outstanding (Basic) | 36 | 32 | 32 | 32 | 32 |
Shares Outstanding (Diluted) | 37 | 32 | 32 | 32 | 32 |
Shares Change (YoY) | 14.25% | -0.03% | - | 0.04% | 1.88% |
EPS (Basic) | 296.00 | -1281.00 | 818.97 | 298.74 | -370.52 |
EPS (Diluted) | 290.00 | -1281.00 | 818.97 | 297.86 | -371.00 |
EPS Growth | - | - | 174.95% | - | - |
Free Cash Flow | 8,396 | -9,604 | 7,328 | 5,401 | 1,257 |
Free Cash Flow Per Share | 229.69 | -300.17 | 228.96 | 168.74 | 39.30 |
Gross Margin | 51.92% | 50.47% | 46.25% | 40.58% | 36.73% |
Operating Margin | 3.76% | 4.67% | 5.30% | 6.21% | -4.46% |
Profit Margin | 3.90% | -16.42% | 12.11% | 5.01% | -7.12% |
Free Cash Flow Margin | 3.09% | -3.85% | 3.38% | 2.83% | 0.76% |
EBITDA | 16,689 | 17,743 | 17,317 | 16,945 | -2,387 |
EBITDA Margin | 6.14% | 7.11% | 8.00% | 8.88% | -1.43% |
D&A For EBITDA | 6,476 | 6,096 | 5,844 | 5,092 | 5,041 |
EBIT | 10,213 | 11,646 | 11,473 | 11,853 | -7,427 |
EBIT Margin | 3.76% | 4.67% | 5.30% | 6.21% | -4.46% |
Effective Tax Rate | 33.03% | - | 9.37% | 10.30% | - |
Advertising Expenses | 280.76 | 246.75 | 430.63 | 430.06 | 194.09 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.